Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases

The administration of mesenchymal stem cells (MSCs) as a therapy for liver disease holds great promise. MSCs can differentiate into hepatocytes, reduce liver inflammation, promote hepatic regeneration and secrete protective cytokines. However, the risks of iatrogenic tumor formation, cellular reject...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Guohua, Chen, Zhi, Zheng, Min, Liu, Yanning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519012/
https://www.ncbi.nlm.nih.gov/pubmed/28620221
http://dx.doi.org/10.1038/emm.2017.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519012/
https://www.ncbi.nlm.nih.gov/pubmed/28620221
http://dx.doi.org/10.1038/emm.2017.63

Ejemplares similares